Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

IM Cannabis Corp (IMCC.CN)

IM Cannabis Corp (IMCC.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 297,361
  • Shares Outstanding, K 67,582
  • Annual Sales, $ 15,890 K
  • Annual Income, $ -28,698 K
  • 60-Month Beta 4.05
  • Price/Sales 6.04
  • Price/Cash Flow N/A
  • Price/Book 2.09
Trade IMCC.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.95
  • Most Recent Earnings -0.23 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.390 +24.78%
on 09/21/21
4.830 -12.42%
on 09/23/21
+0.480 (+12.80%)
since 09/17/21
3-Month
3.390 +24.78%
on 09/21/21
6.670 -36.58%
on 07/26/21
-2.220 (-34.42%)
since 07/16/21
52-Week
3.390 +24.78%
on 09/21/21
14.400 -70.63%
on 03/03/21
-2.650 (-38.52%)
since 10/16/20

Most Recent Stories

More News
IMC Provides Further Details on Panaxia Transaction

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / September 8, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational...

IMCC.CN : 4.230 (-3.86%)
IMCC : 3.41 (-3.94%)
Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th

/PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors,...

IMCC.CN : 4.230 (-3.86%)
INNO.CN : 0.780 (-7.14%)
TGIF.CN : 0.080 (+6.67%)
VIBE.CN : 0.395 (+1.28%)
INM : 1.5300 (+9.29%)
NOVC.TO : 2.99 (-1.64%)
VLNS.TO : 1.95 (+2.63%)
IMCC : 3.41 (-3.94%)
INNPF : 0.6300 (-7.35%)
MRMD : 0.8050 (-3.25%)
NVACF : 2.4200 (-6.92%)
TGIFF : 0.0642 (+9.18%)
VIBEF : 0.3239 (unch)
VLNCF : 1.5600 (+1.09%)
The Flowr Corporation Provides Operational Update

Highlights:

FLWR.VN : 0.105 (+5.00%)
FLWPF : 0.0821 (+2.62%)
IMCC : 3.41 (-3.94%)
IMCC.CN : 4.230 (-3.86%)
TLRY.TO : 12.48 (-1.58%)
IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel

Q2 2021 revenues of $11.1 million, a 27% increase from Q1 2021

IMCC.CN : 4.230 (-3.86%)
IMCC : 3.41 (-3.94%)
IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational...

IMCC : 3.41 (-3.94%)
IMCC.CN : 4.230 (-3.86%)
IMC Announces Results of its Annual General and Special Meeting of Shareholders

IM Cannabis Corp. ("" or the "") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased...

MYMMF : 0.1061 (-2.93%)
IMCC.CN : 4.230 (-3.86%)
IMCC : 3.41 (-3.94%)
IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way

Strategically located, best in class retailer with approximately CAD$8 million in annualized revenuePurchase price of CAD$4.6 million

IMCC : 3.41 (-3.94%)
IMCC.CN : 4.230 (-3.86%)
IM Cannabis Provides Update on German Operations and Financial Outlook

TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical...

IMCC.CN : 4.230 (-3.86%)
IMCC : 3.41 (-3.94%)
IM Cannabis Provides Business, Legal and Regulatory Update

IMC subsidiary, Adjupharm, to expand German product portfolio with unique strains via supply agreements with The Green Organic Dutchman and Natural MedCoGerman Brand Institute awards IMC with the "German...

IMCC.CN : 4.230 (-3.86%)
IMCC : 3.41 (-3.94%)
IM Cannabis Closes Acquisition of MYM Nutraceuticals

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / July 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC)(CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational...

MYMMF : 0.1061 (-2.93%)
IMCC : 3.41 (-3.94%)
IMCC.CN : 4.230 (-3.86%)
MYM.CN : 0.140 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 4.507
2nd Resistance Point 4.403
1st Resistance Point 4.317
Last Price 4.230
1st Support Level 4.127
2nd Support Level 4.023
3rd Support Level 3.937

See More

52-Week High 14.400
Fibonacci 61.8% 10.194
Fibonacci 50% 8.895
Fibonacci 38.2% 7.596
Last Price 4.230
52-Week Low 3.390

See More

Business Summary

IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar